Insider Transactions in Q2 2023 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,662
+50.0%
|
$16,620
$10.68 P/Share
|
|
Jun 30
2023
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
1,228
+0.51%
|
$12,280
$10.68 P/Share
|
|
Jun 30
2023
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
1,662
+0.52%
|
$16,620
$10.68 P/Share
|
|
Jun 27
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
244
-0.08%
|
$2,928
$12.12 P/Share
|
|
Jun 27
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
647
-0.27%
|
$7,764
$12.12 P/Share
|
|
Jun 27
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
294
-0.2%
|
$3,528
$12.12 P/Share
|
|
Jun 27
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
294
-0.22%
|
$3,528
$12.12 P/Share
|
|
May 30
2023
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
161,818
+33.7%
|
-
|
|
May 24
2023
|
Laura Shawver |
SELL
Bona fide gift
|
Direct |
12,099
-23.22%
|
-
|
|
Apr 28
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
863
-0.57%
|
$9,493
$11.16 P/Share
|
|
Apr 28
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
739
-0.47%
|
$8,129
$11.16 P/Share
|
|
Apr 28
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
863
-0.64%
|
$9,493
$11.16 P/Share
|
|
Apr 28
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
1,383
-0.57%
|
$15,213
$11.16 P/Share
|